Resiliency in Green Supply Chains of Pharmaceuticals

Basit Öğe Kaydı
dc.contributor.authorKaradayi-Usta, S.
dc.date.accessioned2024-05-19T14:33:53Z
dc.date.available2024-05-19T14:33:53Z
dc.date.issued2024
dc.departmentİstinye Üniversitesien_US
dc.description.abstractThe pharmaceutical industry, a vital stakeholder in the global market, places a high priority on research and development, and the COVID-19 pandemic led to concerns in April 2020 about possible disruptions in the supply chain of medicines. The pharmaceutical industry must prioritize resilient green supply chain operations in order to mitigate potential disruptions, as indicated in industrial reports. As per the literature, green supply chain management involves the incorporation of the reduce, reuse, recycle, reclaim, and degradable principle into green supply chains, beginning from manufacturing to operations and culminating with end-of-life management. Thus, the purpose of this study is to extract the concepts to achieve the green supply chain for pharmaceutical industry, and to obtain a conceptual framework via cognitive mapping process. The findings of the analysis reveal that biodiversity and corporate social responsibility together provide a basis for the green chemistry and green pharmaceutical production. In case the medical institutions adopt recycling, reverse logistics and waste management operations, a green supply chain can be achieved. Moreover, by adding the digitalization and risk management practices, finally the resiliency in green supply chain of medicine can be attained. As a result, this paper contributes to the literature by extracting the concepts to be green in pharmaceutical supply chain and by analyzing these cognitive maps for these defined concepts. As of the knowledge of the author, this is the first paper conducting a cognitive map for green pharmaceutical supply chains. In addition, practitioner can benefit from this research findings to determine the tactical and strategical plans for their institutions. Accordingly, risk management and digitalization applications plus the green pharmaceutical supply chain brings resiliency. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2024.en_US
dc.identifier.doi10.1007/978-3-031-46735-6_14
dc.identifier.endpage353en_US
dc.identifier.issn2198-4182
dc.identifier.scopus2-s2.0-85182470806en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage337en_US
dc.identifier.urihttps://doi.org/10.1007/978-3-031-46735-6_14
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4361
dc.identifier.volume513en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer Science and Business Media Deutschland GmbHen_US
dc.relation.ispartofStudies in Systems, Decision and Controlen_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectDrugen_US
dc.subjectGreen Supply Chainen_US
dc.subjectHealthcareen_US
dc.subjectMedicationen_US
dc.subjectMedicineen_US
dc.subjectPharmaceuticalen_US
dc.subjectSupply Chainen_US
dc.subjectSustainabilityen_US
dc.titleResiliency in Green Supply Chains of Pharmaceuticalsen_US
dc.typeBook Chapteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu